

(Alliance News) - Ondine Biomedical Inc on Monday announced an update on its Lantern phase 3 pivotal study evaluating the company's non-antibiotic nas...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - Ondine Biomedical Inc on Thursday said higher investment, which is designed to support future growth, impacted margins in 2025.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...